Address:

155A, A .J.C Bose Rd, Moulali. Kolkata - 700014.

48/7, Purna Das Road. Kolkata - 700029

Allergy & Asthma Treatment Centre (AATC) was originally conceived and conceptualized as a treatment centre by Late Prof. (Dr) Sachin Choudhuri, MB. PhD. a renowned clinical Immunologist and Late Brig. (Dr) Niren Das, MB. DARCP&S (Lon), FICS, FCCP (USA) a Vir Chakra awardee and also a renowned Pulmonologist.

Since its inception in late 1980s, AATC has been striving hard to attain a scientific and rational approach to the diagnosis and treatment of allergic and other atopic disorders.

Allergy & Asthma Treatment Centre (AATC) was set up 1980s by the joint efforts of renowned clinical Immunologist Late Prof (Dr) Sachin Choudhuri, MB. PhD and renowned Pulmonologist and Vir Chakra recipient Late Brig (Dr) Niren Das, MB, DARCP&S (Lon), FICS, FCCP (USA).

Presently headed by Dr. Arijit Das (Managing Director), one of the leading allergists and ably supported by his eminent allergist and Pulmoonologist colleagues Dr. Saibal Moitra, Dr Aratrika Das and others.

 

AATC has successfully established a standard practice and continues to grow under the able leadership of eminent allergists Dr Arijit Das (Managing Director), Dr Saibal Moitra and Dr Aratrika Das, towards attaining a scientific and rational approach to the diagnosis and treatment of allergic and other atopic disorders.

 

Although various survey reports reveal that about 250 million Indians or nearly 25% of the total Indian population suffer from one or more allergic disorders, awareness among the general public about the magnitude of this problem and the available ways and means for it’s cessation is extremely low. One of the prime objectives of AATC would be to make earnest endeavours to rectify the situation as well as offer the available contemporary solutions in a more scientific and rational manner. The diagnostic set-up (N. C. Das Immunomedicare Pvt. Ltd.) has been catering to vast multitude of patients from within the state of West Bengal and adjoining states as well as neighbouring Bangladesh for a considerable period of time now and has in the process developed a comprehensive and competent infrastructure, manned by vastly experienced and trained clinicians and technologists to tackle the common and persistent problems of Bronchial Asthma, Allergic Rhinitis, Allergic Conjunctivitis, Atopic Urticaria and other allergic dermatoses on a more methodical and comprehensive basis.

 

Presently 250 million Indians or nearly 25% of the total Indian population suffer from one or more allergic disorders which results from inadequate awareness about the magnitude of this problem and the available solutions.

 

AATC endeavours to raise awareness and offer available contemporary solutions in a more scientific and rational manner.

 

The state of the art diagnostic set up of N C Das Immunomedicare Pvt Ltd has been assisting patients from West Bengal, neighbouring Indian states and across  Bangladesh through their well experienced and trained clinicians and technologists identifing and managing Bronchial Asthma, Allergic Rhinitis, Allergic Conjunctivitis, Atopic Urticaria and other allergic dermatoses.

 

 

Having conducted supportive research projects in the past with Indian Council of Medical Research (ICMR) and the Department of Science and Technology (DST), Govt. of India, the Centre has developed an array of immunological tests and other diagnostic methods ranging from simple skin-tests to the more complex serological assessments of specific allergenicities known as “Allergy Profiles” by the ELISA method for the determination of allergic modalities involved.

 

AATC having been extensively involved in the supportive research projects with Indian Council of Medical Research (ICMR) and the Department of Science and Technology (DST), Government of India and has successfully developed an array of immunological tests and other diagnostic methods ranging from simple skin tests to the most complex serological assessments of specific allergenicites known as “Allergy Profiles” by the ELISA method for determination of allergic modalities involved.

 

Additionally, there also exists in the clinic well equipped Respiratory and Pathological Laboratories possessing facilities for the accurate and computerised assessment of lung functional, radiological, general and specialised serological parameters, specifically relating to cases of Bronchial Asthma and Chronic Obstructive Pulmonary diseases (COPD). It is envisaged in the very near future to incorporate appurtenant facilities for computerised blood gas assessments and bronchoscopic examinations. Plans for total and comprehensive in-house care facilities for chronic patients and acute respiratory cases are also being drawn up together with a COPD Management Centre, Sleep Study facilities and a Centre for Critical Care Medicine, in the not too distant future.

The clinic already has well equipped Respiratory and Pathological Laboratories facilitating accurate and computerized assessment of lung function, radiological, general and specialized serological parameters specifically relating to Bronchial Asthma and Chronic Obstructive Pulmonary Diseases (COPD). Expansion plans include facilities for computerized blood gas assessments and bronchoscopic examinations, total and comprehensive in-house care facilities for chronic patients and acute respiratory cases,  COPD Management Centre, Sleep Study facilities and a Centre for Critical Care Management are in the pipeline.